Patient characteristics and changes in anxiety symptoms in patients with panic disorder: Post-hoc analysis of the PARADIES cluster randomised trial.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
01
2022
accepted:
15
09
2022
entrez:
29
9
2022
pubmed:
30
9
2022
medline:
4
10
2022
Statut:
epublish
Résumé
Anxiety disorders are among the most common mental health problems in primary care. The PARADIES (Patient Activation foR Anxiety DIsordErS) intervention combined elements of cognitive behavioural therapy with case management and has demonstrated efficacy. Our aim was to explore patient characteristics, which may influence the course of anxiety symptoms over a 12 months period. Multiple linear regression was used to quantify associations of baseline characteristics (demographics, clinical parameters, medication use) with changes in anxiety symptoms as measured by the Beck anxiety inventory. Treatment modalities (e.g. adherence to appointment schedules) were considered as confounders. We examined univariate associations between dependent and independent variables before considering all independent variables in a multivariate final model. To find the best model to explain BAI score changes, we performed step-wise selection of independent variables based on Akaike information criteria. We tested for interaction terms between treatment allocation (intervention vs control) and independent variables using the multivariate model. We repeated these analyses in control vs intervention groups separately. From the original trial (N = 419), 236 patients (56.3%) were included. In the multivariate model, receiving the intervention (p<0.001), higher anxiety symptom severity (p<0.001) and longer illness duration at baseline (p = 0.033) were significantly associated with changes in anxiety symptom severity to the better while depression severity at baseline (p<0.001) was significantly associated with changes in anxiety symptoms to the worse. In stratified analyses, the control group showed significant associations between depression symptom severity and illness duration with anxiety symptom changes while baseline severity of anxiety symptoms remained significantly associated with anxiety symptom changes in both groups. A brief primary-care-based exposure training combined with case management is effective in a broad range of patients with panic disorder with/without agoraphobia, including those with longer illness duration and co-existing symptoms of depression at baseline.
Identifiants
pubmed: 36174096
doi: 10.1371/journal.pone.0275509
pii: PONE-D-22-02155
pmc: PMC9521898
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0275509Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Clin Psychol. 2014 Oct;70(10):924-32
pubmed: 24752934
Trials. 2014 Apr 06;15:112
pubmed: 24708672
J Clin Epidemiol. 2017 Nov;91:70-79
pubmed: 28802672
Prim Care. 2016 Jun;43(2):245-61
pubmed: 27262005
Dialogues Clin Neurosci. 2011;13(4):413-21
pubmed: 22275847
EMBO Rep. 2016 Sep;17(9):1245-9
pubmed: 27491723
J Nerv Ment Dis. 2007 Jun;195(6):521-31
pubmed: 17568301
Prim Care Companion J Clin Psychiatry. 2000 Jun;2(3):71-79
pubmed: 15014652
Psychiatr Serv. 2015 Mar 1;66(3):265-71
pubmed: 25727114
Clin Psychol Rev. 2015 Jun;38:39-54
pubmed: 25795293
J Affect Disord. 2011 Sep;133(1-2):76-85
pubmed: 21496929
BMC Fam Pract. 2016 Jun 02;17:62
pubmed: 27250527
Am J Manag Care. 2012 Feb 01;18(2):e55-60
pubmed: 22435885
Dialogues Clin Neurosci. 2015 Sep;17(3):327-35
pubmed: 26487813
Psychol Med. 2019 Jun;49(8):1266-1274
pubmed: 30688184
Psychol Med. 2006 Mar;36(3):353-63
pubmed: 16403243
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Behav Ther. 2016 Mar;47(2):155-65
pubmed: 26956649
J Gen Intern Med. 2020 Apr;35(4):1120-1126
pubmed: 31965532
Depress Anxiety. 1996-1997;4(4):160-8
pubmed: 9166648
Curr Top Behav Neurosci. 2010;2:21-35
pubmed: 21309104
JAMA. 2010 May 19;303(19):1921-8
pubmed: 20483968
Br J Psychiatry. 1997 Nov;171:427-33
pubmed: 9463600
Dtsch Arztebl Int. 2019 Mar 8;116(10):159-166
pubmed: 30995952
Br J Psychiatry. 2013 Jul;203(1):65-72
pubmed: 23580378
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
Behav Res Ther. 2013 Aug;51(8):434-42
pubmed: 23747582
Depress Anxiety. 2014 Aug;31(8):678-89
pubmed: 24619599
BMC Geriatr. 2011 Sep 13;11:54
pubmed: 21914191
J Consult Clin Psychol. 2009 Aug;77(4):595-606
pubmed: 19634954
Prim Care Companion J Clin Psychiatry. 2007;9(3):173-9
pubmed: 17632648
Br J Gen Pract. 2005 Oct;55(519):763-9
pubmed: 16212851